According to Bloomberg, defence technology startup Anduril Industries Inc. is partnering with Microsoft Corp. to enhance the performance of advanced combat goggles for the US Army. Anduril announced Thursday that this project could generate up to $21.9 billion in revenue over the next decade.
Anduril is one of the hottest tickets on secondary platforms, where demand far exceeds supply. Since its primary funding round in June, which valued the company at $14 billion, Anduril’s implied valuation on Launchbay Platform has surged by 23%.
OpenAI’s latest fundraising round is nearing completion, with prospective investors expected to learn on Friday whether they’ll be part of the deal. The $6.5 billion round is reportedly oversubscribed, meaning investors wanted to commit more capital than OpenAI was willing to accept, said the sources, who requested anonymity due to the private nature of the information.
As the secondary market expands rapidly, investors who missed out on the primary round may soon have another chance. OpenAI, which accounts for nearly 75% of listed volume in bids on the secondary market according to ApeVue, still saw $180 million in ask volume over the past three months.
Meanwhile, general artificial intelligence startup Anthropic is reportedly seeking to raise new funding at a valuation of up to $40 billion.
How is this valuation compared to OpenAI’s coming 150B valuation?
Revolut is reportedly planning to launch its own stablecoin, joining the ranks of PayPal, Ripple, and BitGo in the expanding stablecoin sector. The timing is significant, as Revolut recently secured a U.K. banking licence.
The stablecoin space has been buzzing with activity, and both liquidity and supply are on the rise. The total supply of fiat-backed stablecoins (1:1 backed by the US dollar or its equivalent) has now reached an all-time high of $165 billion.
Revolut is also stepping up to challenge trading giants Robinhood and eToro with the launch of its standalone retail wealth app, Revolut Invest.
According to Sifted, French healthtech unicorn Alan has secured a €173M Series F funding round, boosting its valuation to €4 billion. Alan, which offers health insurance for businesses and employees, was previously valued at €2.7 billion following its €183M Series E in 2022. Since its founding in 2016, the company has raised a total of €654M.
Since its founding in 2016, Alan has raised a total of €654M. The company projects its annual recurring revenue (ARR) to reach €450M (around $500M) this year, translating to a 9x EV/Revenue multiple at its current valuation. This stands as a positive benchmark for insurtech startups, especially when compared to Wefox, which is listed on the secondary market at over an 80% discount from its last primary round. Despite reporting a €739M ARR, Wefox's valuation reflects just a 1x EV/Revenue multiple.